Filing Flows

Filing Flows › Phibro Animal Health (PAHC) › Q4 FY26

Phibro Animal Health (PAHC) Q4 FY26 earnings results (fourth quarter fiscal 2026)

10-K filed Aug 26, 2026

Phibro Animal Health (PAHC) reported revenue of $397M for the fourth quarter fiscal 2026 (Q4 FY26), +5% from a year earlier and +3% from the quarter before. Operating margin was 12.1%, net earnings $21.7M (5.5% of revenue).

Revenue$397M
Year over year+5%
Quarter over quarter+3%
Operating margin12.1%
Net earnings$21.7M

Phibro Animal Health, Q4 FY26: revenue $397M (+5% year over year), operating margin 12.1%, net earnings $21.7M, operating cash flow $24.1M. The chart follows the revenue to costs, profit and cash.

Q4 FY26AmountQ/QY/Y
Revenue$397M+3%+5%
Gross profit$134M+7%+22%
Operating profit$48.2M+8%+43%
Net earnings$21.7M-10%+26%
Operating cash flow$24.1M+49%+13%
Free cash flow$5.2M+487%-36%

What changed

Revenue was $396.7M in Q4 FY26, up 5% year over year and up 3% from the previous quarter. MFAs and other was the largest line at 52% of revenue.

Gross margin was 33.9%, up 4.8 points from Q4 FY25. Operating profit was $48.2M, a 12.1% margin (up 3.2 points year over year). Of the extra revenue versus Q4 FY25, 80% reached operating profit, above the 9% margin then. Operating expenses grew 13% against revenue growth of 5%. Net earnings were $21.7M, up 26% year over year. The effective tax rate was 32.9%.

Operating cash flow was $24.1M (up 13% year over year), 111% of net earnings. Non-cash charges added back $13.3M of depreciation and amortization and $413K of share-based compensation. Working capital and other items used $11.4M. Capital expenditures of $18.9M left free cash flow of $5.2M.

Questions

What was Phibro Animal Health's revenue in the fourth quarter fiscal 2026?

Phibro Animal Health (PAHC) reported revenue of $397M for the fourth quarter fiscal 2026 (Q4 FY26), +5% from a year earlier and +3% from the quarter before.

Was Phibro Animal Health profitable in the fourth quarter fiscal 2026?

Operating profit was $48.2M (12.1% of revenue) and net earnings $21.7M.

Open the interactive Sankey →

Source: Phibro Animal Health 10-K on SEC EDGAR.